SUN PHARMACEUTICAL INDUSTRIES
|
The Current P/B Ratio of SUN PHARMACEUTICAL INDUSTRIES is 6.82.
Share Price | ₹1,808.8 | Nov 04,2024 |
Market Cap | ₹433,985.4 Cr | |
Book Value | ₹63,666.8 Cr | Mar2024 - Consolidated Results |
Price/Book | 6.82x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of SUN PHARMACEUTICAL INDUSTRIES
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹433,985.4 Cr] as on Nov 04,2024
(/) Book Value [ ₹63,666.8 Cr] based on Mar2024 - Consolidated Results
(=) P/B Ratio [ 6.82x ]
Thus, for SUN PHARMACEUTICAL INDUSTRIES , the investors are currently willing to pay '6.82 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of SUN PHARMACEUTICAL INDUSTRIES !
The chart below summarizes the trend in P/B Ratio of SUN PHARMACEUTICAL INDUSTRIES over the last five years.
Historical PB (Price/Book ) ratio chart of SUN PHARMACEUTICAL INDUSTRIES
PB Ratio Performance Analysis for SUN PHARMACEUTICAL INDUSTRIES
- SUN PHARMACEUTICAL INDUSTRIES 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 3.97x.
- SUN PHARMACEUTICAL INDUSTRIES 's operated at median p/b ratio of 4.21x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, SUN PHARMACEUTICAL INDUSTRIES 's p/b ratio peaked in Mar2024 at 6.11x.
- SUN PHARMACEUTICAL INDUSTRIES 's p/b ratio hit its five-year low in Mar2020 of 1.87x.
How does SUN PHARMACEUTICAL INDUSTRIES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
SUN PHARMACEUTICAL INDUSTRIES | 63,666.80 | 6.82 | 433,985.4 |
CIPLA LTD | 26,619.90 | 4.81 | 127,968.0 |
DR REDDYS LABORATORIES LTD | 28,123.50 | 3.76 | 105,796.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 5.10 | 101,056.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.53 | 156,498.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.73 | 109,574.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.79 | 108,250.0 |
LUPIN LTD | 14,175.80 | 7.04 | 99,847.4 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.74 | 81,733.3 |
ABBOTT INDIA LTD | 3,658.73 | 17.11 | 62,599.5 |
ALKEM LABORATORIES LTD | 10,292.50 | 6.73 | 69,302.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs SUN PHARMACEUTICAL INDUSTRIES 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.74x |
Max industry PB | 17.11x |
Median industry PB | 6.82x |
Average industry PB | 8.47x |
You may also like the below Video Courses